论文信息 - Long-term safety of intracameral moxifloxacin after cataract surgery. - 字舞流文

Long-term safety of intracameral moxifloxacin after cataract surgery.

Rodrigo Pessoa Cavalcanti Lira | N. Lucena | Kaline Sandrelli Alves Ferreira | B. M. A. D. Santos | Bruna Marília Alves dos Santos

[1] M. Gillies,et al. Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture. , 2016, JAMA ophthalmology.

[2] L. Kodjikian,et al. Moxifloxacin superior to cefuroxime in reducing bacterial adhesion of Staphylococcus epidermidis on hydrophobic intraocular lenses , 2016, Acta ophthalmologica.

[3] K. Matsuura. Long-term effects of intracameral moxifloxacin , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4] S. Yamagami,et al. Comparison of toxicities of moxifloxacin, cefuroxime, and levofloxacin to corneal endothelial cells in vitro , 2014, Journal of cataract and refractive surgery.

[5] C. Suto,et al. Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan , 2013, Journal of cataract and refractive surgery.

[6] E. Moisseiev,et al. Anaphylactic reaction following intracameral cefuroxime injection during cataract surgery. , 2013, Journal of cataract and refractive surgery.

[7] S. Masket,et al. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery , 2008, Journal of cataract and refractive surgery.

[8] V. Caparas,et al. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients , 2007, Journal of cataract and refractive surgery.